On Monday, Spineway reported lower sales for the 3rd quarter, marked by a less favorable perimeter effect, but this did not prevent it from posting a strong increase in business for the first nine months.

The implant manufacturer, specializing in minimally invasive spine treatments, posted sales of 2.1 million euros for the quarter, down 8%.

But sales for the first nine months of the year came to 7.5 million euros, up 40% on last year.

The designer of surgical instruments explains that sales growth was mainly driven by the integration of Spine Innovations, a company consolidated since July 2022.

In Europe, sales jumped 101% to 3.6 million euros by the end of September, driven in particular by strong momentum in France (+67% to 2.1 million euros).

The share gained nearly 14% on the Paris Bourse after these figures, but continued to trade close to its all-time lows.

Copyright (c) 2023 CercleFinance.com. All rights reserved.